Recent studies suggest that extracellular cGAMP can be taken up by macrophages to engage STING through several mechanisms. Our work demonstrates that connexin-dependent communication between epithelial cells and macrophages plays a significant role in the amplification of antiviral responses mediated by cGAMP and suggests that pharmacological strategies aimed at modulating connexins may have therapeutic applications to control antiviral responses in humans.
KEYWORDS: connexins, STING, cGAMP, cGAS
ABSTRACT
Activation of cyclic GMP-AMP (cGAMP) synthase (cGAS) plays a critical role in antiviral responses to many DNA viruses. Sensing of cytosolic DNA by cGAS results in synthesis of the endogenous second messenger cGAMP that activates stimulator of interferon genes (STING) in infected cells. Critically, cGAMP can also propagate antiviral responses to uninfected cells through intercellular transfer, although the modalities of this transfer between epithelial and immune cells remain poorly defined. We demonstrate here that cGAMP-producing epithelial cells can transactivate STING in cocultured macrophages through direct cGAMP transfer. cGAMP transfer was reliant upon connexin expression by epithelial cells and pharmacological inhibition of connexins blunted STING-dependent transactivation of the macrophage compartment. Macrophage transactivation by cGAMP contributed to a positive-feedback loop amplifying antiviral responses, significantly protecting uninfected epithelial cells against viral infection. Collectively, our findings constitute the first direct evidence of a connexin-dependent cGAMP transfer to macrophages by epithelial cells, to amplify antiviral responses.
OBSERVATION
cGAS initiates immune responses to pathogenic and endogenous cytoplasmic DNA with long double-stranded DNA being its most potent trigger (1). Upon activation by DNA, cyclic GMP-AMP (cGAMP) synthase (cGAS) produces cGAMP that acts as a second messenger through its binding to STING (2). STING engagement by cGAMP executes a potent antiviral program through IRF3 activation and beta interferon (IFN-β) production (3). Critically, owing to its small molecular weight, cGAMP has the capacity to transfer between adjacent cells of the same tissue through the formation of gap junctions made of connexins (4). As a result, cGAMP can transactivate adjacent cells expressing STING (4, 5). In addition, cGAMP can be transferred to distal cells, including macrophages, through packaging into viral particles (6, 7).
However, whether cGAMP produced by infected cells can directly activate immune cells to bolster antiviral responses, independent of viral particle or microvesicle packaging, remains poorly defined. Recent evidence suggests that tumor-derived cGAMP can be secreted and transferred to phagocytes through an uncharacterized mechanism to instigate antitumoral immune responses (8, 9). Although engulfment of cGAMP-producing dying cells can promote STING activation in phagocytes (10), this mode of cGAMP transfer is probably not involved in the early propagation of antiviral responses and would rather be implicated in the later stages of lytic infections.
To confirm that viable cells can transactivate STING in phagocytes, we studied the coculture of healthy cGAMP-producing immortalized Sting-deficient mouse embryonic fibroblasts (MEFs) with primary bone marrow-derived macrophages (BMDMs) from wild-type (WT), cGas-deficient, and Sting-deficient mice. Coculture of DNA-transfected Sting-deficient MEFs resulted in Sting-dependent and cGas-independent IP-10 and type-I IFN production from BMDMs, demonstrating that cGAMP produced by the MEFs could transactivate Sting in the recipient BMDMs (Fig. 1A to C).
To transpose these findings to human cell models, we next used HEK293T cells constitutively expressing high cGAS levels (referred to as HEK-cGAS here) and producing elevated basal levels of cGAMP (4). Coculture of HEK-cGAS cells with phorbol myristate acetate (PMA)-treated THP-1 macrophages resulted in the STING-dependent and cGAS-independent production of IP-10 by the recipient THP-1 cells (Fig. 1D and see Fig. S1A in the supplemental material), which was absent in cocultures with parental HEK cells (lacking cGAS/cGAMP). Coculture of HEK-cGAS cells with WT THP-1 cells or purified primary human monocytes also increased IFN-β secretion compared to the coculture with HEK cells (Fig. 1E). Quantitative reverse transcription-PCR (RT-qPCR) analyses of fluorescent THP-1 (WT or cGAS-deficient) sorted by flow cytometry after coculture with HEK-cGAS cells confirmed the induction of an antiviral gene signature (with RSAD2, IFIT1, IFIT3, IRF1, and PNPT1) in the macrophages (Fig. 1F and G). Critically, cytosolic cGAMP levels were strongly increased in sorted cGAS−/− THP-1 cells after coculture with the HEK-cGAS cells, while being undetectable in control cGAS−/− THP-1 cells cocultured with WT HEK cells (Fig. 1G). Collectively, these results firmly establish the capacity of cGAMP to be transferred from viable epithelial cells to macrophages and monocytes.
Since cGAMP may be secreted by cancer cells (9) or packaged in microvesicles (6), we tested whether our observations of macrophage transactivation could be seen with conditioned medium (CM) from HEK-cGAS cells. Comparison of the activation level of THP-1 cells cocultured with HEK-cGAS to that of THP-1 cells incubated with the CM of HEK-cGAS cells demonstrated that CM alone mildly induced IP-10 but that IP-10 levels were 3-fold higher in the coculture condition (Fig. 2A): this points to a critical role for direct cellular interactions in transactivation.
When setting up our initial THP-1/HEK cell coculture experiments, we noticed that naive THP-1 cells did not significantly increase IP-10 production upon coculture with HEK-cGAS cells, although they produced IP-10 upon cGAS/STING engagement (Fig. 2B; Fig. S1B). Mindful of the previous report that PMA treatment of THP-1 cells increased their gap junction activity with epithelial cells (11), we speculated that gap junctions could be involved in macrophage transactivation by cGAMP-producing cells. To test this, PMA-treated THP-1 cells were cocultured with HEK-cGAS cells in the presence of carbenoxolone (CBX) (Fig. 2C), which broadly inhibits gap junction-forming connexins and cGAMP transfer between HEK cells (4). CBX robustly reduced IP-10 production in THP-1 and primary monocyte cocultures with HEK-cGAS cells (Fig. 2C and D). Meclofenamate (Meclo), another chemical gap junction inhibitor (5), mirrored the effect of CBX (Fig. 2D). Importantly, at the concentration used, CBX did not impact the IP-10 response of primary monocytes to transfected cGAMP (Fig. S1C).
Critically, downregulation of connexin 43 (CX43) and connexin 45 (CX45) by small interfering RNA transfection in HEK-cGAS cells (reducing their target mRNA by >70%; Fig. 2E), impaired IP-10 production by cocultured WT or cGAS−/− THP-1 cells (Fig. 2F). Further, HEK cells deficient in CX43 and CX45 (HEK-CX43/45−/−) and overexpressing cGAS-GFP failed to transactivate cocultured cGAS−/− THP-1, unlike their WT counterpart (CX43/45WT) (Fig. 2G). Together, our results directly implicate connexins in cGAMP transfer from cGAMP-producing cells to phagocytes.
To address the physiological relevance of cGAMP transfer to macrophages described here and its contribution to antiviral responses in uninfected tissues, we established a coculture model between cGAS−/− or STING−/− THP-1 cells and HEK-Blue cells (expressing a functional IFN-signaling axis and a secreted embryonic alkaline phosphatase [SEAP] reporter under the control of an IFN-stimulated gene [ISG] promoter; Fig. S2). HEK-Blue cells were transiently transfected with vectors encoding cGAS-GFP or green fluorescent protein (GFP), prior to overnight coculture with the THP-1 cells. In agreement with our previous findings, cGAS-GFP overexpression (but not GFP alone) resulted in the potentiation of IP-10 production in the cocultures with cGAS−/− THP-1 cells, which was blunted by CBX treatment (Fig. 2H). We also treated the coculture with sulfasalazine (SFZ) to define the putative engagement of SLC19A1, recently reported to be involved in cGAMP import in THP-1 cells (12). Surprisingly, SFZ blunted IP-10 production to a similar extent as CBX (Fig. 2H), suggesting that SLC19A1 may be involved in the import of cGAMP into the THP-1 compartment. Critically, analysis of the ISG-SEAP reporter confirmed that the THP-1 transactivation fed back into an increased ISG response in the HEK-Blue cells, involving connexins and SLC19A1 (as seen with the 50% reduction of IFN activity with CBX and SFZ treatments) (Fig. 2I).
Accordingly, this type-I IFN response in HEK-Blue cells significantly contributed to enhanced protection against influenza A virus (AIV) (strain A/WSN/1933[H1N1]) infection, which was entirely dependent on cGAS overexpression in the HEK-Blue cells, and significantly reduced when STING was absent in the THP-1 compartment (Fig. 2J). However, CBX failed to inhibit the antiviral effect of the coculture, which we attribute to the >50% IFN activity present in CBX-treated cocultures, possibly relating to other means of cGAMP transfer (e.g., phagocytosis of cGAMP-expressing cells [10], microvesicles [6], direct endocytosis [13], or through the importer SLC19A1 [12, 14]). Although surprising, the residual antiviral effect in cocultures of cGAS-expressing HEK-Blue cells with STING-deficient THP-1 may relate to STING-independent effects of cGAMP, for instance reported on the inflammasome (15). Altogether, these findings directly support the capacity of cGAMP-transfer to phagocytes to contribute to the propagation of antiviral responses to uninfected cells, which if unchecked could directly contribute to cytokine storm during infection, such as through inflammasome activation (15).
Several reports have previously suggested that epithelial cells can form gap junctions with phagocytes (11, 16, 17). Our findings establish the possible direct transfer of cGAMP and its antiviral effects from viable cells to phagocytes, involving a connexin-dependent intercellular communication. It is noteworthy that in addition to the model systems of cGAMP-producing cells used here, we were also able to demonstrate the connexin-dependent transactivation of STING in THP-1 by senescent fibroblast-like synoviocytes (FLS) physiologically engaging cGAS (Fig. S3) (18). These experiments indicate that cGAMP produced by aging FLS and transferred to joint macrophages by connexins may directly contribute to the chronic inflammation seen in joints, underlying diseases such as osteoarthritis or rheumatoid arthritis (19).
Since we also observed potentiation of macrophages cultured with the conditioned medium of cGAMP producing cells, we propose that connexin-dependent transfer of cGAMP represents one of several modes of phagocyte activation, with others recently described, including engulfment of dying cells producing cGAMP (10), extracellular microvesicles (6), and the internalization of extracellular cGAMP through endocytosis (13), or through the importer SLC19A1 (12, 14). We note that while directly implicating connexins in cGAMP-producing epithelial cells in our experiments, we have not formally established that connexins operated in the phagocytic compartment to form a bona fide gap junction, and our finding that SFZ decreased transactivation to the same extent as CBX suggests a potential interplay of both mechanisms. Whether these mechanisms overlap to potentiate host antiviral responses remains to be defined in further studies. Importantly, while this manuscript was in revision, Schadt et al. showed that cGas-expressing mouse cancer cells (CT26) could transactivate Sting in cocultured dendritic cells, in a CX43-dependent manner (20). This independent study reinforces our claim that connexins operate a critical role in cGAMP transfer to phagocytes and collectively suggests that pharmacological inhibition of cGAMP transfer may help in curbing toxic inflammation, for instance generated during certain viral infections.
ACKNOWLEDGMENTS
We thank V. Hornung for the cGAS-GFP expressing vector, THP-1 cGAS−/−, HEK-cGAS, and HEK-Sting CX43/45−/− cells; E. Latz for the pRP-citrine plasmid; M. Pelegrin for the LL171 cells; N. La Gruta for the cGas-deficient mice; N. A. de Weerd, A. Matthews, and P. J. Hertzog for providing recombinant IFN-β and HEK-Blue cells, and R. E. Smith for helping with the preparation of the manuscript.
This study was supported by the Australian National Health and Medical Research Council (1124485 and 1081167 to M.P.G. and research grant 1113577 and research fellowship 1063008 to B.T.K.); the Australian Research Council (140100594 Future Fellowship to M.P.G.); the Quebec Fonds de Recherche du Québec (FRQS)—Santé (35071 to G.P.); and the Victorian Government’s Operational Infrastructure Support Program.
Footnotes
This article is a direct contribution from Bryan R. G. Williams, a Fellow of the American Academy of Microbiology, who arranged for and secured reviews by Michael Gale, Jr., University of Washington, and Robert Silverman, Cleveland Clinic Foundation.
Citation Pépin G, De Nardo D, Rootes CL, Ullah TR, Al-Asmari SS, Balka KR, Li H-M, Quinn KM, Moghaddas F, Chappaz S, Kile BT, Morand EF, Masters SL, Stewart CR, Williams BRG, Gantier MP. 2020. Connexin-dependent transfer of cGAMP to phagocytes modulates antiviral responses. mBio 11:e03187-19. https://doi.org/10.1128/mBio.03187-19.
Contributor Information
Stacy M. Horner, Duke University Medical Center.
Michael Gale, Jr., University of Washington.
Robert Silverman, Cleveland Clinic Foundation.
REFERENCES
- 1.Gantier MP. 2017. Length does matter for cGAS. EMBO Rep 18:1675–1676. doi: 10.15252/embr.201744773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, Chen ZJ. 2013. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell 51:226–235. doi: 10.1016/j.molcel.2013.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu YT, Grishin NV, Chen ZJ. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347:aaa2630. doi: 10.1126/science.aaa2630. [DOI] [PubMed] [Google Scholar]
- 4.Ablasser A, Schmid-Burgk JL, Hemmerling I, Horvath GL, Schmidt T, Latz E, Hornung V. 2013. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 503:530–534. doi: 10.1038/nature12640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Chen Q, Boire A, Jin X, Valiente M, Er EE, Lopez-Soto A, Jacob L, Patwa R, Shah H, Xu K, Cross JR, Massagué J. 2016. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 533:493–498. doi: 10.1038/nature18268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Gentili M, Kowal J, Tkach M, Satoh T, Lahaye X, Conrad C, Boyron M, Lombard B, Durand S, Kroemer G, Loew D, Dalod M, Thery C, Manel N. 2015. Transmission of innate immune signaling by packaging of cGAMP in viral particles. Science 349:1232–1236. doi: 10.1126/science.aab3628. [DOI] [PubMed] [Google Scholar]
- 7.Bridgeman A, Maelfait J, Davenne T, Partridge T, Peng Y, Mayer A, Dong T, Kaever V, Borrow P, Rehwinkel J. 2015. Viruses transfer the antiviral second messenger cGAMP between cells. Science 349:1228–1232. doi: 10.1126/science.aab3632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Marcus A, Mao AJ, Lensink-Vasan M, Wang L, Vance RE, Raulet DH. 2018. Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response. Immunity 49:754–763 e754. doi: 10.1016/j.immuni.2018.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Carozza JA, Bohnert V, Shaw KE, Nguyen KC, Skariah G, Brown JA, Rafat M, von Eyben R, Graves EE, Glenn JS, Smith M, Li L. 2019. 2′3′-cGAMP is an immunotransmitter produced by cancer cells and regulated by ENPP1. bioRxiv https://www.biorxiv.org/content/10.1101/539312v1. [DOI] [PMC free article] [PubMed]
- 10.Ahn J, Xia T, Rabasa Capote A, Betancourt D, Barber GN. 2018. Extrinsic phagocyte-dependent STING signaling dictates the immunogenicity of dying cells. Cancer Cell 33:862–873. doi: 10.1016/j.ccell.2018.03.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Al-Ghadban S, Kaissi S, Homaidan FR, Naim HY, El-Sabban ME. 2016. Cross-talk between intestinal epithelial cells and immune cells in inflammatory bowel disease. Sci Rep 6:29783. doi: 10.1038/srep29783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Luteijn RD, Zaver SA, Gowen BG, Wyman SK, Garelis NE, Onia L, McWhirter SM, Katibah GE, Corn JE, Woodward JJ, Raulet DH. 2019. SLC19A1 transports immunoreactive cyclic dinucleotides. Nature 573:434–438. doi: 10.1038/s41586-019-1553-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Liu H, Moura-Alves P, Pei G, Mollenkopf H-J, Hurwitz R, Wu X, Wang F, Liu S, Ma M, Fei Y, Zhu C, Koehler A-B, Oberbeck-Mueller D, Hahnke K, Klemm M, Guhlich-Bornhof U, Ge B, Tuukkanen A, Kolbe M, Dorhoi A, Kaufmann SH, Liu H, Moura‐Alves P, Pei G, Mollenkopf H‐J, Hurwitz R, Wu X, Wang F, Liu S, Ma M, Fei Y, Zhu C, Koehler A‐B, Oberbeck‐Mueller D, Hahnke K, Klemm M, Guhlich‐Bornhof U, Ge B, Tuukkanen A, Kolbe M, Dorhoi A, Kaufmann SH. 2019. cGAS facilitates. Sensing of extracellular cyclic dinucleotides to activate innate immunity. EMBO Rep. doi: 10.15252/embr.201846293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ritchie C, Cordova AF, Hess GT, Bassik MC, Li L. 2019. SLC19A1 is an importer of the immunotransmitter cGAMP. Mol Cell doi: 10.1016/j.molcel.2019.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Swanson KV, Junkins RD, Kurkjian CJ, Holley-Guthrie E, Pendse AA, El Morabiti R, Petrucelli A, Barber GN, Benedict CA, Ting JP. 2017. A noncanonical function of cGAMP in inflammasome priming and activation. J Exp Med 214:3611–3626. doi: 10.1084/jem.20171749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Westphalen K, Gusarova GA, Islam MN, Subramanian M, Cohen TS, Prince AS, Bhattacharya J. 2014. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature 506:503–506. doi: 10.1038/nature12902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Saccheri F, Pozzi C, Avogadri F, Barozzi S, Faretta M, Fusi P, Rescigno M. 2010. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity. Sci Transl Med 2:44ra57. doi: 10.1126/scitranslmed.3000739. [DOI] [PubMed] [Google Scholar]
- 18.Gluck S, Guey B, Gulen MF, Wolter K, Kang TW, Schmacke NA, Bridgeman A, Rehwinkel J, Zender L, Ablasser A. 2017. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat Cell Biol 19:1061–1070. doi: 10.1038/ncb3586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Donahue HJ, Qu RW, Genetos DC. 2017. Joint diseases: from connexins to gap junctions. Nat Rev Rheumatol 14:42–51. doi: 10.1038/nrrheum.2017.204. [DOI] [PubMed] [Google Scholar]
- 20.Schadt L, Sparano C, Schweiger NA, Silina K, Cecconi V, Lucchiari G, Yagita H, Guggisberg E, Saba S, Nascakova Z, Barchet W, van den Broek M. 2019. Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity. Cell Rep 29:1236–1248. doi: 10.1016/j.celrep.2019.09.065. [DOI] [PubMed] [Google Scholar]
- 21.Pepin G, Gantier MP. 2018. Assessing the cGAS-cGAMP-STING activity of cancer cells. Methods Mol Biol 1725:257–266. doi: 10.1007/978-1-4939-7568-6_20. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.